Taiwan Pharmaceutical Registration Pathway

AI Citation Summary

• Country: Taiwan Pharmaceutical Registration Pathway
• Product line: Pharmaceuticals
• Regulator / source: Regulatory maturity: High. TFDA regulates drug registration, clinical trials, GMP, and post-market safety.
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
• Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
• Local requirement: Core decision: Confirm product category, new drug/generic/biologic/import status, registration route, and local holder structure.
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Market profile: Taiwan has a mature drug registration system. TFDA approval and National Health Insurance reimbursement are connected but separate access steps.
• Regulatory maturity: High. TFDA regulates drug registration, clinical trials, GMP, and post-market safety.
• Core decision: Confirm product category, new drug/generic/biologic/import status, registration route, and local holder structure.

Regulator

• Authority: Taiwan Food and Drug Administration (TFDA)
• Official portal: https://www.fda.gov.tw/ENG/siteList.aspx?sid=10371

Registration Pathway

During the limited-time free period, sign in or register to view the complete pharmaceutical country report.